Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
The Fly
AbbVie price target lowered to $230 from $235 at Citi
3d ago
ABBV
Premium
The Fly
AbbVie price target raised to $275 from $270 at Berenberg
11d ago
ABBV
Premium
The Fly
AbbVie announces results for epcoritamab from Phase 3 EPCORE DLBCL-1 trial
14d ago
ABBV
GMAB
Premium
The Fly
Genmab says OS in Phase 3 trial did not reach statistical significance
14d ago
ABBV
GMAB
Premium
The Fly
Midday Fly By: PNC reports Q4 beat, Regions reports quarterly miss
14d ago
RF
CEG
Premium
The Fly
Trump Trade: Trump says utility bills higher due to big tech data centers
17d ago
GM
SPY
Premium
The Fly
AbbVie announces voluntary agreement with the Trump administration
18d ago
ABBV
Premium
The Fly
AbbVie, RemeGen announce exclusive licensing agreement for RC148
18d ago
ABBV
Premium
The Fly
West Pharmaceutical to sell SmartDose 3.5mL rights to AbbVie for $112.5M
18d ago
WST
ABBV
Premium
The Fly
AbbVie to acquire Arizona manufacturing facility, IP from West Pharmaceutical
18d ago
WST
ABBV
Premium
The Fly
Revolution Medicines price target raised to $147 from $80 at Wedbush
21d ago
MRK
ABBV
Premium
The Fly
Wolfe downgrades AbbVie with outperformance already priced in
22d ago
ABBV
Premium
The Fly
AbbVie downgraded to Peer Perform from Outperform at Wolfe Research
22d ago
ABBV
Premium
The Fly
Revolution Medicines down 15% in after-hours after AbbVie denies takeover talks
23d ago
ABBV
RVMD
Premium
The Fly
AbbVie tells Bloomberg not in talks to buy Revolution Medicines
23d ago
ABBV
RVMD
Premium
The Fly
AbbVie says not in discussions with Revolution Medicines, Reuters reports
23d ago
ABBV
RVMD
Premium
The Fly
Erasca up 66% after WSJ report on AbbVie interest in Revolution Medicines
23d ago
ABBV
ERAS
Premium
The Fly
Revolution Medicines extends gain to 29% after resuming trading
23d ago
ABBV
RVMD
Premium
The Fly
Revolution Medicines near deal to be bought by AbbVie, WSJ says
23d ago
ABBV
RVMD
Premium
The Fly
AbbVie near deal to buy Revolution Medicines, WSJ reports
23d ago
ABBV
RVMD
Premium
The Fly
AbbVie assumed with a Neutral at UBS
24d ago
ABBV
Premium
Ratings
AbbVie: Premium Valuation, Strong Long-Duration Growth, but Balanced Risk/Reward Supports Hold Rating
24d ago
ABBV
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.